News articles about Aethlon Medical (NASDAQ:AEMD) have been trending somewhat positive on Tuesday, according to Accern Sentiment. The research group identifies positive and negative media coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Aethlon Medical earned a news impact score of 0.10 on Accern’s scale. Accern also assigned news headlines about the medical equipment provider an impact score of 45.9852841214264 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near future.
Several analysts have weighed in on AEMD shares. ValuEngine upgraded Aethlon Medical from a “strong sell” rating to a “sell” rating in a research note on Friday, September 1st. HC Wainwright started coverage on Aethlon Medical in a research note on Monday, November 20th. They issued a “buy” rating and a $3.00 target price on the stock.
Shares of Aethlon Medical (NASDAQ AEMD) traded up $0.01 on Tuesday, hitting $1.03. The stock had a trading volume of 97,500 shares, compared to its average volume of 205,359. Aethlon Medical has a 1 year low of $0.79 and a 1 year high of $5.17. The company has a current ratio of 2.97, a quick ratio of 2.97 and a debt-to-equity ratio of 78.00.
COPYRIGHT VIOLATION WARNING: “Somewhat Positive Media Coverage Somewhat Unlikely to Impact Aethlon Medical (AEMD) Stock Price” was posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this piece of content on another publication, it was copied illegally and republished in violation of US and international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.chaffeybreeze.com/2017/12/05/somewhat-positive-media-coverage-somewhat-unlikely-to-impact-aethlon-medical-aemd-stock-price.html.
About Aethlon Medical
Aethlon Medical, Inc is a medical device company focused on creating devices for cancer, infectious disease and other life-threatening conditions. The Company operates through two segments: Aethlon, which represents its therapeutic business activities, and ESI, which represents its diagnostic business activities.
Receive News & Ratings for Aethlon Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.